BD reorganizes into five segments; provides recast historical revenue data

BECTON DICKINSON & CO

New segments effective Oct 1, 2025: Medical Essentials, Connected Care, BioPharma Systems, Interventional, Life Sciences.
Life Sciences segment to be eliminated after planned combination of Biosciences/Diagnostic Solutions with Waters Corp (announced July 13, 2025).
Exhibit 99.1 furnishes recast segment revenues for FY2025 and quarterly periods, including non-GAAP measures.
Segment reorganization does not affect principal product lines of any organizational unit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.